ATI PROCTORED EXAM REMEDIATION|PHARMACOLOGY II (2022) Complete solution guide.

ATI PROCTORED EXAM REMEDIATION CAIT BLACKFORD PHARMACOLOGY II DR. PHILLIPS 1. SAFETY AND INFECTION CONTROL a. ACCIDENT/ERROR/INJURY PREVENTION i. SAFE MEDICATION ADMINISTRATION AND ERROR REDUCTION: ADMINISTERING PHENYTOIN ii. ANTIBIOTICS AFFECTING THE BACTERIAL CELL WALL: PRIORITY FINDING AFTER A PENICILLIN INJECTION iii. REPORTING OF INCIDENT/EVENT/IRREGULAR OCCURRENCE/VARIANCE 1. SAFE MEDICATION ADMINISTRATION AND ERROR REDUCTION: PRIORITY ACTION FOR INCORRECT MEDICATION DOSAGE 2. SAFE MEDICATION ADMINISTRATION AND ERROR REDUCTION: INDENTIFY A SITUATION REQUIRING AN INCIDENT REPORT 3. MISCELLANEOUS CENTRAL NERVOUS SYSTEM MEDICATIONS: TREATMENT FOR MUSCARINIC POISONING 2. PSYCHOSOCIAL INTEGRITY a. CHEMICAL AND OTHER DEPENDENCIES/SUBSTANCE USE DISORDER 3. PHARMACOLOGICAL AND PARENTERAL THERAPIES 1. MISCELLANEOUS PAIN MEDICATIONS: ADVERSE EFFECTS OF ERGOTAMINE 2. MEDICATIONS AFFECTING BLOOD PRESSURE: ADVERSE EFFECTS OF ABRUPT PROPRANOLO WITHDRAWL 3. MEDICATIONS EFFECTING COAGULATION: ADVERSE EFFECTS OF CLOPIDOGREL NURSING CONSIDERATIONS 4. ANTIBIOTICS AFFECTING THE BACTERIAL CELL WALL: ALLERGIC REACTIONS TO CEPHALOSPORINS 5. ENDOCRINE DISORDERS: ADVERSE EFFECTS OF THYROID HORMONE 6. MEDICATIONS AFFECTING COAGULATION: LABORATORY RESULTS TO REPORT a. 7. ANTIBIOTICS AFFECTING PROTEIN SYNTHESIS: DIETARY SUPPLEMENT INTERACTIONS WITH TETRACYCLINE 8. IMMUNIZATIONS: CONTRAINDICATION FOR RECEIVING VARICELLA VACCINE 9. ANTILIPEMIC AGENTS: DETERMINING AFFECTIVENESS OF TREATMENT 10. MYCOBACTERIAL, FUNGAL, AND PARASITIC INFECTIONS: EVALUATING USE OF ANTI-INFECTIVE MEDICATIONS 11. MEDICATIONS AFFECTING URINARY OUTPUT: 12. MEDICATIONS AFFECTING LABOR AND DELIVERY: PRIORITY ACTION FOR A CLIENT RECEIVING OXYTOCIN a. 13. ADVERSE EFFECTS, INTERACTIONS, AND CONTRAINDICATIONS: PRIORITY TREATMENT FOR ANAPHYLAXIS a. 14. ENDOCRINE DISORDERS: ID A NEED FOR A DOSAGE INCREASE OF LEVOTHYROXINE a. 15. URINARY TRACT INFECTIONS: EVALUATING CLIENT RESPONSE TO AN ANALGESIC a. 16. CARDIAC GLYCOSIDES AND HEART FAILURE: ASSESSING FOR DIGOXIN TOXICITY ii. MEDICATION ADMINISTRATION 1. MEDICATIONS AFFECTING COAGULATION: SELF ADMINISTRATION OF ENOXAPARIN 2. ANGINA: CLIENT TEACHING FOR A NEW PRESCRIPTION OF SUBLINGUAL NITROGLYCERIN 3. AIRFLOW DISORDERS: THERAPEUTIC ACTION OF MONTELUKAST 4. MEDICATIONS AFFECTING BLOOD PRESSURE: TITRATING CONTINUOUS NITROPRUSSIDE INFUSION 5. SAFE MEDICATION ADMINISTRATION AND ERROR REDUCTION: REVIEWING A MEDICATION ADMINISTRATION RECORD 6. MEDICATION AFFECTING COAGULATION: MONITORING LABORATORY RESULTS FOR WARFARIN ADMINISTRATION 7. DIABETES MELLITUS: EVALUATING UNDERSTANDING OF INSULIN SELF ADMINISTRATION 8. ANTIBIOTICS AFFECTING PROTEIN SYNTHESIS: UNDERSTANDING TEACHING ABOUT TETRACYCLINE 9. ANTIBIOTICS AFFECTING THE BACTERIAL CELL WALL PROPER INJECTION TECHNIQUE 10. MEDICATIONS AFFECTING BLOOD PRESSURE: CLIENT EDUCATION FOR ADRENERGIC BETA BLOCKERS 11. PEPTIC ULCER DISEASE: ANTACID THERAPY 12. MEDICATIONS AFFECTING URINARY OUTPUT: MONITORING FOR LABORATORY VALUES iii. PARENTERAL/INTRAVENOUS THERAPIES iv. PHARMACOLOGICAL PAIN MANAGEMENT 1. OPIOD AGOIST AND ANTAGONISTS: FINDINGS TO REPORT TO THE PROVIDER